Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Odeion String Quartet performs in Tanzania and Austria
2016-11-18

Description: Odeion String Quartet performs in Tanzania and Austria Tags: Odeion String Quartet performs in Tanzania and Austria

The Odeion String Quartet will build
international relationships when
it visits Tanzania and Austria.
Photo: Supplied

To be an ambassador for the University of the Free State (UFS) is a goal of the Odeion String Quartet (OSQ) and that is exactly what it will do through international visits to Tanzania and Austria. The OSQ, the only residential university quartet in South Africa, will play concerts abroad, share knowledge and build relationships.

It visits Dar es Salaam, Tanzania, from 17 to 20 November 2016 and Austria from 29 November to 4 December 2016. The quartet, which constitutes string lecturers at the Odeion School of Music, consists of Samson Diamond, Sharon de Kock, Jeanne-Louise Moolman and Prof Anmari van der Westhuizen Joubert.

A humbling experience
The OSQ was invited by Hekima Raymond, founder and conductor of the Dar Choral Society, to Tanzania to assist the symphony orchestra. Raymond is a self-taught pianist and conductor and was nominated for a BBC Outlook Inspirations award in 2016.

The quartet will lead the string sections of the orchestra, consisting of members from Uganda, Kenya and Tanzania, performing Beethoven’s fifth symphony and Verdi’s Requiem.

According to Diamond it is a humbling experience, an opportunity to extend their services and help establish the Dar Choral Society. “You are part of something really special, because the circumstances are remote if you compare it to what we have here.”

He means it is important to have a real African footprint and being involved there can later serve as a platform for UFS recruitment.

“You are part of something really special,
because the circumstances are remote if
you compare it to what we have here.”

South African and Austrian collaboration
According to Prof Van der Westhuizen Joubert it is an honour to play in Austria, as Europe is a centre for classical music. The OSQ will play concerts at the Alte Schmiede, Vienna, and the University of Salzburg.

The concert on 4 December 2016 at the University of Salzburg’s Mozarteum is a highlight because the UFS will have the opportunity to build relationships with the famous music school.

Prof Van der Westhuizen Joubert said it would be a South African/Austrian collaboration. “We will bring them South African works (Mokale Koapeng, AJ Feder, Arnold van Wyk and Peter-Louis van Dijk) and will be playing Austrian contemporary string quartets.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept